Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Noriaki, Yamashita"'
Autor:
Noriaki Yamashita, Masahiro Kawahara, Takayuki Imai, Goichi Tatsumi, Ai Asai-Nishishita, Akira Andoh
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Thiopurines, such as 6-mercaptopurine (6-MP), are widely used as cytotoxic agents and immunosuppressants for leukemia and autoimmune or inflammatory diseases. A nonsynonymous single nucleotide polymorphism (p.Arg139Cys; R139C) of the nucleos
Externí odkaz:
https://doaj.org/article/3c96629815534cc8a1d0fa30ceebdd8c
Autor:
Osamu Inatomi, Takayuki Imai, Takehide Fujimoto, Kenichiro Takahashi, Yoshihiro Yokota, Noriaki Yamashita, Hiroshi Hasegawa, Atsushi Nishida, Shigeki Bamba, Mitsushige Sugimoto, Akira Andoh
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) often requires deep sedation. Dexmedetomidine, a highly selective α2-adrenoceptor agonist with sedative activity and minimal effects on respiration, has recently been widely u
Externí odkaz:
https://doaj.org/article/23b37cc9d8144f96b2b1114af8a0c9fe
Autor:
Shoichiro Matsuo, Kenji Yamashiro, Yusuke Tsujimoto, Noriaki Yamashita, Okimi Mukai, Yusuke Sasaki, Katsuhiro Takenaga
Publikováno v:
2022 27th OptoElectronics and Communications Conference (OECC) and 2022 International Conference on Photonics in Switching and Computing (PSC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8ab5a909ca16d1fa9243ced677325dc
https://doi.org/10.23919/oecc/psc53152.2022.9850036
https://doi.org/10.23919/oecc/psc53152.2022.9850036
Autor:
Noriaki Yamashita, Goichi Tatsumi, Ai Nishishita-Asai, Akira Andoh, Masahiro Kawahara, Yoichi Kakuta, Takayuki Imai, Atsushi Masamune, Osamu Inatomi
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 1, Pp 335-337 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5db3cd2a4676f8ad6e2dc8ff2cd2202
http://www.sciencedirect.com/science/article/pii/S2352345X21000588
http://www.sciencedirect.com/science/article/pii/S2352345X21000588
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Vedolizumab is a humanized monoclonal antibody against the α4β7 integrin and is approved for treatment of inflammatory bowel diseases. In this study, we evaluated the immunogenicity of vedolizumab using a simple drug-tolerant assay developed in our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9398efbecf0d1383d87d94575c8a6f5
https://pubmed.ncbi.nlm.nih.gov/35068684
https://pubmed.ncbi.nlm.nih.gov/35068684
Autor:
Atsushi Nishida, Noriaki Yamashita, Shigeki Bamba, Kenichiro Takahashi, Yoshihiro Yokota, Akira Andoh, Mitsushige Sugimoto, Takayuki Imai, Hiroshi Hasegawa, Takehide Fujimoto, Osamu Inatomi
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Gastroenterology
BMC Gastroenterology
Background Endoscopic retrograde cholangiopancreatography (ERCP) often requires deep sedation. Dexmedetomidine, a highly selective α2-adrenoceptor agonist with sedative activity and minimal effects on respiration, has recently been widely used among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8419c9e6cdeebd43858c8fab36859d60
https://doi.org/10.1186/s12876-018-0897-5
https://doi.org/10.1186/s12876-018-0897-5
Publikováno v:
Wire Journal International; Dec2021, Vol. 54 Issue 12, p61-65, 5p
Autor:
Nobuyuki Miyasaka, Naonobu Sugiyama, Noriaki Yamashita, N. Sugiyama, Bonnie Vlahos, Hirotoshi Yuasa, Lorin Craig Wagerle, Tsutomu Takeuchi, Shinichi Kawai, Joseph Wajdula
Publikováno v:
Modern Rheumatology
Conventional synthetic disease-modifying anti-rheumatic drugs, including methotrexate, may not be tolerated by all patients with rheumatoid arthritis (RA), and limited international data for etanercept (ETN) monotherapy are available. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e297596c9fa0cf1d717eb315dd9a44
https://doi.org/10.3109/14397595.2014.914014
https://doi.org/10.3109/14397595.2014.914014
Publikováno v:
The Journal of Clinical Pharmacology. 54:513-519
Safety, tolerability, and pharmacokinetics of tigecycline in 76 healthy Japanese subjects were determined in three randomized, double-blind, placebo-controlled studies. Subjects in an ascending single-dose study (n = 40) received 25-150 mg intravenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f7341ad981ad67f4313ae31dded06ed
https://doi.org/10.1002/jcph.236
https://doi.org/10.1002/jcph.236
Autor:
Shinichi Tsuchiwata, Hanjui Liu, Joan M. Korth-Bradley, Noriaki Yamashita, Shinichi Kawai, Hisayuki Sekino
Publikováno v:
The Journal of Clinical Pharmacology. 46:418-423
Thirty Japanese (J) and 32 American (A) healthy subjects received single doses of etanercept by subcutaneous injection, in 3 separate trials. Serum samples were collected for 480 hours after dosing. Concentrations were determined using enzyme-linked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701a32267bfac9cb51fbf983b7776251
https://doi.org/10.1177/0091270006286435
https://doi.org/10.1177/0091270006286435